Microfluidic devices integrated with plasmonic nanostructures for sensitive fluorescent immunoassays.
Xuefeng Xu, Guangyang Li1, Lingyue Xue1
1College of Information Science and Electronic Engineering, Zhejiang University, Hangzhou 310027, People's Republic of China.
Biomicrofluidics
|February 16, 2024
Summary
This study discusses advanced microfluidic devices with plasmonic nanostructures for highly sensitive fluorescent immunoassays. These innovations aim to improve biomarker detection for point-of-care diagnostics, especially in underserved areas.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Analytical Chemistry
Background:
- Fluorescent immunoassays are crucial for biomarker detection in diagnostics and precision medicine.
- Current assays lack sensitivity and are complex, hindering point-of-care applications.
- Microfluidic devices with plasmonic nanostructures offer enhanced sensitivity and simplified operation.
Purpose of the Study:
- To review recent advancements in microfluidic devices integrated with plasmonic nanostructures for fluorescent immunoassays.
- To highlight strategies for nanofabrication and fluidic design for sensitive antigen detection.
- To discuss future perspectives for practical applications of these integrated systems.
Main Methods:
- Review of recent literature on plasmonic nanostructures and microfluidic devices for immunoassays.
- Discussion of nanofabrication techniques for plasmonic nanostructures.
- Analysis of various microfluidic designs for enhanced assay performance.
Main Results:
- Plasmonic nanostructures significantly enhance the sensitivity of fluorescent immunoassays.
- Integrated microfluidic devices enable rapid, efficient, and multiplexed biomarker detection.
- Novel designs address limitations of conventional immunoassay methods.
Conclusions:
- Microfluidic-plasmonic devices represent a significant advancement for sensitive biomarker detection.
- These technologies hold great potential for improving point-of-care diagnostics, particularly in resource-limited settings.
- Further research into integration and application is warranted for widespread clinical adoption.


